25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

CPMD (Cannapharmarx) Stock Analysis
Buy, Hold or Sell?

Let's analyze Cannapharmarx together

I guess you are interested in CannaPharmaRx Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • ๐Ÿ“Š Fundamental Analysis (FA) โ€“ Cannapharmarxโ€™s Financial Insights
  • ๐Ÿ“ˆ Technical Analysis (TA) โ€“ Cannapharmarxโ€™s Price Targets

I'm going to help you getting a better view of CannaPharmaRx Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about CannaPharmaRx Inc

I send you an email if I find something interesting about CannaPharmaRx Inc.

1. Quick Overview

1.1. Quick analysis of Cannapharmarx (30 sec.)










1.2. What can you expect buying and holding a share of Cannapharmarx? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
3.0%

What is your share worth?

Current worth
$-0.03
Expected worth in 1 year
$-0.02
How sure are you?
36.4%

+ What do you gain per year?

Total Gains per Share
$0.01
Return On Investment
170.1%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.002 - $0.0055
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cannapharmarx (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$-0.02 - $0.00
Total Value Per Share
$-0.05 - $-0.03

2.2. Growth of Cannapharmarx (5 min.)




Is Cannapharmarx growing?

Current yearPrevious yearGrowGrow %
How rich?-$19.8m-$18.6m$412.6k2.3%

How much money is Cannapharmarx making?

Current yearPrevious yearGrowGrow %
Making money-$482.7k-$1.5m$1m218.4%
Net Profit Margin-372.9%-12,750.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Cannapharmarx (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cannapharmarx?

Welcome investor! Cannapharmarx's management wants to use your money to grow the business. In return you get a share of Cannapharmarx.

First you should know what it really means to hold a share of Cannapharmarx. And how you can make/lose money.

Speculation

The Price per Share of Cannapharmarx is $0.0033. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cannapharmarx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cannapharmarx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.03. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cannapharmarx.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-171.1%0.00-22.1%0.00-75.6%0.00-62.6%0.00-98.3%0.00-106.2%
Usd Book Value Change Per Share0.000.0%0.0042.5%0.00-60.8%0.00-21.1%0.00-48.2%0.00-26.7%
Usd Dividend Per Share0.000.0%0.000.0%0.002.3%0.000.8%0.000.5%0.000.3%
Usd Total Gains Per Share0.000.0%0.0042.5%0.00-58.6%0.00-20.3%0.00-47.8%0.00-26.4%
Usd Price Per Share0.00-0.01-0.01-0.01-0.13-0.50-
Price to Earnings Ratio-0.18-1.86--1.27--0.22--6.90--671.81-
Price-to-Total Gains Ratio22.51-6.39-2.27-25.53--2,852.37-
Price to Book Ratio-0.13--0.33--0.32--0.39-22.09--421.51-
Price-to-Total Gains Ratio22.51-6.39-2.27-25.53--2,852.37-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0033
Number of shares303030
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (303030 shares)425.36-477.54
Gains per Year (303030 shares)1,701.43-1,910.17
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101701169118-1928-1920
203403339236-3857-3830
305104509354-5785-5740
406806679472-7713-7650
508507849591-9641-9560
601020910196109-11570-11470
701191011897127-13498-13380
801361113598145-15426-15290
901531315299163-17354-17200
1001701417000181-19283-19110

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%3.09.00.025.0%4.016.00.020.0%4.029.00.012.1%7.061.00.010.3%
Book Value Change Per Share2.01.01.050.0%3.07.02.025.0%7.011.02.035.0%11.018.04.033.3%20.043.05.029.4%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%1.00.032.03.0%3.00.065.04.4%
Total Gains per Share2.01.01.050.0%4.07.01.033.3%8.011.01.040.0%12.018.03.036.4%21.043.04.030.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of CannaPharmaRx Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-100%-0.0020%-0.0010%-0.0020%-0.0010%
Book Value Per Share---0.030-0.027-8%-0.028-6%-0.027-11%-0.020-33%-0.011-64%
Current Ratio--0.0400.053-26%0.027+46%0.028+39%0.024+62%0.128-69%
Debt To Asset Ratio--2.8282.625+8%3.640-22%3.420-17%8.383-66%6.994-60%
Debt To Equity Ratio----0%-0%-0%0.757-100%0.915-100%
Dividend Per Share----0%0.000-100%0.000-100%0.000-100%0.000-100%
Enterprise Value---27993172.380-23732947.507-15%-21905928.454-22%-19766045.603-29%63558442.953-144%347139240.796-108%
Eps---0.006-0.001-87%-0.002-56%-0.002-63%-0.003-43%-0.004-38%
Ev To Ebitda Ratio--1.99610.078-80%15.797-87%9.508-79%-13.696+786%-214.152+10828%
Ev To Sales Ratio---14.515-15.231+5%-209.065+1340%-92.764+539%-92.764+539%-92.764+539%
Free Cash Flow Per Share--0.000-0.001+85%-0.001+226%-0.001+122%-0.001+117%-0.001+155%
Free Cash Flow To Equity Per Share--0.0000.000-24%0.000-118%0.000+782%0.000+1164%0.000+660%
Gross Profit Margin--1.0020.997+0%1.055-5%1.017-2%1.018-2%0.980+2%
Intrinsic Value_10Y_max---0.003----------
Intrinsic Value_10Y_min---0.025----------
Intrinsic Value_1Y_max---0.002----------
Intrinsic Value_1Y_min---0.003----------
Intrinsic Value_3Y_max---0.005----------
Intrinsic Value_3Y_min---0.008----------
Intrinsic Value_5Y_max---0.006----------
Intrinsic Value_5Y_min---0.013----------
Market Cap2186253.274-21%2650005.6205747198.243-54%6542197.296-59%6801677.564-61%85634878.653-97%330953374.602-99%
Net Profit Margin---7.759-3.729-52%-127.504+1543%-43.744+464%-26.247+238%-15.907+105%
Operating Margin---7.091-2.128-70%-116.644+1545%-39.591+458%-23.754+235%-14.397+103%
Operating Ratio--4.1553.844+8%17.933-77%7.259-43%4.355-5%2.640+57%
Pb Ratio-0.110+18%-0.134-0.326+144%-0.322+140%-0.387+189%22.088-101%-421.510+314992%
Pe Ratio-0.146+18%-0.1771.864-110%-1.268+616%-0.221+25%-6.898+3795%-671.812+379241%
Price Per Share0.003-21%0.0040.009-54%0.010-59%0.010-61%0.129-97%0.500-99%
Price To Free Cash Flow Ratio-3.038+18%-3.683-4.799+30%3.064-220%-1.038-72%-49.095+1233%-444.331+11965%
Quick Ratio--0.0010.005-84%-0.069+7965%-0.021+2460%-0.010+1196%0.079-99%
Return On Assets---0.345-0.054-84%-0.191-45%-0.214-38%-3.454+900%-2.561+642%
Return On Equity----0%-0%-0%-0.1180%-0.5630%
Total Gains Per Share---0.001-100%-0.0020%-0.0010%-0.0020%-0.0010%
Usd Book Value---19809637.000-18218085.250-8%-18630751.250-6%-17719926.500-11%-13199921.150-33%-7210956.970-64%
Usd Book Value Change Per Share---0.001-100%-0.0020%-0.0010%-0.0020%-0.0010%
Usd Book Value Per Share---0.030-0.027-8%-0.028-6%-0.027-11%-0.020-33%-0.011-64%
Usd Dividend Per Share----0%0.000-100%0.000-100%0.000-100%0.000-100%
Usd Enterprise Value---27993172.380-23732947.507-15%-21905928.454-22%-19766045.603-29%63558442.953-144%347139240.796-108%
Usd Eps---0.006-0.001-87%-0.002-56%-0.002-63%-0.003-43%-0.004-38%
Usd Free Cash Flow---179890.000-332074.250+85%-586984.500+226%-399541.500+122%-390253.600+117%-458903.606+155%
Usd Free Cash Flow Per Share--0.000-0.001+85%-0.001+226%-0.001+122%-0.001+117%-0.001+155%
Usd Free Cash Flow To Equity Per Share--0.0000.000-24%0.000-118%0.000+782%0.000+1164%0.000+660%
Usd Market Cap2186253.274-21%2650005.6205747198.243-54%6542197.296-59%6801677.564-61%85634878.653-97%330953374.602-99%
Usd Price Per Share0.003-21%0.0040.009-54%0.010-59%0.010-61%0.129-97%0.500-99%
Usd Profit---3740841.000-482749.250-87%-1536898.250-59%-1396032.500-63%-2234437.400-40%-2373422.758-37%
Usd Revenue--482134.000319108.000+51%12698.250+3697%110602.083+336%66361.250+627%40218.939+1099%
Usd Total Gains Per Share---0.001-100%-0.0020%-0.0010%-0.0020%-0.0010%
 EOD+1 -6MRQTTM+8 -27YOY+13 -203Y+15 -185Y+18 -1610Y+15 -19

3.3 Fundamental Score

Let's check the fundamental score of CannaPharmaRx Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.146
Price to Book Ratio (EOD)Between0-1-0.110
Net Profit Margin (MRQ)Greater than0-7.759
Operating Margin (MRQ)Greater than0-7.091
Quick Ratio (MRQ)Greater than10.001
Current Ratio (MRQ)Greater than10.040
Debt to Asset Ratio (MRQ)Less than12.828
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.345
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of CannaPharmaRx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.003
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About CannaPharmaRx Inc

CannaPharmaRX, Inc. evaluates, negotiates, acquires, and develops various cannabis cultivation projects in Canada. The company is based in Calgary, Canada.

Fundamental data was last updated by Penke on 2025-04-22 12:29:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitย Cannapharmarx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareย Cannapharmarx to theย Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -775.9%ย means thatย $-7.76 for each $1ย in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of CannaPharmaRx Inc:

  • The MRQ is -775.9%. The company is making a huge loss. -2
  • The TTM is -372.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-775.9%TTM-372.9%-403.0%
TTM-372.9%YOY-12,750.4%+12,377.5%
TTM-372.9%5Y-2,624.7%+2,251.8%
5Y-2,624.7%10Y-1,590.7%-1,034.0%
4.3.1.2. Return on Assets

Shows howย efficientย Cannapharmarx is using its assets to generate profit.

  • Above 5% is considered healthyย but always compareย Cannapharmarx to theย Drug Manufacturers - Specialty & Generic industry mean.
  • -34.5% Return on Assets means thatย Cannapharmarx generatedย $-0.35 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of CannaPharmaRx Inc:

  • The MRQ is -34.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-34.5%TTM-5.4%-29.1%
TTM-5.4%YOY-19.1%+13.7%
TTM-5.4%5Y-345.4%+340.0%
5Y-345.4%10Y-256.1%-89.3%
4.3.1.3. Return on Equity

Shows how efficient Cannapharmarx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareย Cannapharmarx to theย Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Cannapharmarx generated $0.00ย for eachย $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of CannaPharmaRx Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-11.8%+11.8%
5Y-11.8%10Y-56.3%+44.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of CannaPharmaRx Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measuresย how efficient Cannapharmarx is operatingย .

  • Measures how much profit Cannapharmarx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareย Cannapharmarx to theย Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -709.1%ย means the company generated $-7.09 ย for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of CannaPharmaRx Inc:

  • The MRQ is -709.1%. The company is operating very inefficient. -2
  • The TTM is -212.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-709.1%TTM-212.8%-496.3%
TTM-212.8%YOY-11,664.4%+11,451.6%
TTM-212.8%5Y-2,375.4%+2,162.7%
5Y-2,375.4%10Y-1,439.7%-935.8%
4.3.2.2. Operating Ratio

Measures how efficient Cannapharmarx is keepingย operating costsย low.

  • Below 1 is considered healthy (always compare toย Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 4.15 means that the operating costs are $4.15 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of CannaPharmaRx Inc:

  • The MRQ is 4.155. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.844. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.155TTM3.844+0.311
TTM3.844YOY17.933-14.088
TTM3.8445Y4.355-0.511
5Y4.35510Y2.640+1.716
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of CannaPharmaRx Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cannapharmarx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toย Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.04ย means the company has $0.04 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of CannaPharmaRx Inc:

  • The MRQ is 0.040. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.053. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.040TTM0.053-0.014
TTM0.053YOY0.027+0.026
TTM0.0535Y0.024+0.029
5Y0.02410Y0.128-0.103
4.4.3.2. Quick Ratio

Measures if Cannapharmarx is able to pay off Short-term Debt but only usingย theย most liquid assets.

  • Above 1 is considered healthy butย always compareย Cannapharmarx to theย Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.00ย means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of CannaPharmaRx Inc:

  • The MRQ is 0.001. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.005. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.001TTM0.005-0.005
TTM0.005YOY-0.069+0.074
TTM0.0055Y-0.010+0.015
5Y-0.01010Y0.079-0.088
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of CannaPharmaRx Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %ย of Cannapharmarxย assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareย Cannapharmarx to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 2.83ย means that Cannapharmarx assets areย financed with 282.8% credit (debt) and the remaining percentage (100% - 282.8%)ย is financed by its owners/shareholders.ย 

Let's take a look of the Debt to Asset Ratio trends of CannaPharmaRx Inc:

  • The MRQ is 2.828. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.625. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.828TTM2.625+0.203
TTM2.625YOY3.640-1.015
TTM2.6255Y8.383-5.758
5Y8.38310Y6.994+1.388
4.5.4.2. Debt to Equity Ratio

Measures ifย Cannapharmarx is able toย pay off its debts by usingย shareholders equity.

  • Below 2 is considered healthy butย always compareย Cannapharmarx to theย Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of CannaPharmaRx Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.757-0.757
5Y0.75710Y0.915-0.158
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measuresย how much money you payย for each share forย every $1 in earnings Cannapharmarx generates.

  • Above 15 is considered overpriced butย always compareย Cannapharmarx to theย Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -0.18 means the investor is paying $-0.18ย for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of CannaPharmaRx Inc:

  • The EOD is -0.146. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.177. Based on the earnings, the company is expensive. -2
  • The TTM is 1.864. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-0.146MRQ-0.177+0.031
MRQ-0.177TTM1.864-2.041
TTM1.864YOY-1.268+3.132
TTM1.8645Y-6.898+8.762
5Y-6.89810Y-671.812+664.914
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of CannaPharmaRx Inc:

  • The EOD is -3.038. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.683. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.799. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.038MRQ-3.683+0.644
MRQ-3.683TTM-4.799+1.116
TTM-4.799YOY3.064-7.863
TTM-4.7995Y-49.095+44.296
5Y-49.09510Y-444.331+395.237
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofย Cannapharmarx is to cheap or to expensiveย compared to its book value.

  • At or below 1 is considered healthyย (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of -0.13 means the investor is paying $-0.13ย for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of CannaPharmaRx Inc:

  • The EOD is -0.110. Based on the equity, the company is expensive. -2
  • The MRQ is -0.134. Based on the equity, the company is expensive. -2
  • The TTM is -0.326. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.110MRQ-0.134+0.023
MRQ-0.134TTM-0.326+0.192
TTM-0.326YOY-0.322-0.005
TTM-0.3265Y22.088-22.415
5Y22.08810Y-421.510+443.598
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Total Operating Expenses  608-263345-2041421,8441,986-2,156-170



6.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets10,836
Total Liabilities30,645
Total Stockholder Equity-19,810
 As reported
Total Liabilities 30,645
Total Stockholder Equity+ -19,810
Total Assets = 10,836

Assets

Total Assets10,836
Total Current Assets1,019
Long-term Assets9,817
Total Current Assets
Cash And Cash Equivalents 2
Net Receivables 20
Inventory 996
Total Current Assets  (as reported)1,019
Total Current Assets  (calculated)1,019
+/-0
Long-term Assets
Property Plant Equipment 5,299
Long-term Assets  (as reported)9,817
Long-term Assets  (calculated)5,299
+/- 4,518

Liabilities & Shareholders' Equity

Total Current Liabilities25,752
Long-term Liabilities4,893
Total Stockholder Equity-19,810
Total Current Liabilities
Short-term Debt 9,168
Accounts payable 4,784
Other Current Liabilities 11,801
Total Current Liabilities  (as reported)25,752
Total Current Liabilities  (calculated)25,752
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)4,893
Long-term Liabilities  (calculated)0
+/- 4,893
Total Stockholder Equity
Common Stock66
Retained Earnings -101,184
Accumulated Other Comprehensive Income 556
Other Stockholders Equity 80,123
Total Stockholder Equity (as reported)-19,810
Total Stockholder Equity (calculated)-20,439
+/- 629
Other
Cash and Short Term Investments 2
Liabilities and Stockholders Equity 10,836
Net Debt 14,058
Net Working Capital -24,734
Short Long Term Debt Total 14,060



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-09-301999-12-311999-09-301999-06-301999-03-311998-12-31
> Total Assets 
2,270
6,350
5,790
5,510
9,600
0
0
0
40
6
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,979
2,452
1,797
1,597
1,093
323
0
0
0
22
759
10,098
10,098
21,014
22,468
16,017
13,318
16,037
16,449
8,748
8,786
8,849
7,039
114
5,914
5,763
5,420
5,414
5,271
5,271
5,156
11,746
11,366
11,714
11,681
10,836
10,836
10,83610,83611,68111,71411,36611,7465,1565,2715,2715,4145,4205,7635,9141147,0398,8498,7868,74816,44916,03713,31816,01722,46821,01410,09810,098759220003231,0931,5971,7972,4521,979000000000000000000000036400009,6005,5105,7906,3502,270
   > Total Current Assets 
20
1,240
930
840
4,590
0
0
0
40
6
3
0
0
0
0
0
-211
-4
-4
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
1,979
2,440
1,649
1,425
1,000
233
0
0
0
22
759
599
599
132
1,475
1,931
102
5
247
468
441
481
282
30
86
35
102
100
104
104
54
1,196
1,047
1,521
1,497
1,019
1,019
1,0191,0191,4971,5211,0471,1965410410410010235863028248144146824751021,9311,475132599599759220002331,0001,4251,6492,4401,9790000000000000-4-4-4-2110000036400004,5908409301,24020
       Cash And Cash Equivalents 
20
1,060
460
250
4,350
0
0
0
40
6
3
0
0
0
0
0
-211
-4
-4
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
1,979
2,440
1,605
1,385
938
201
0
0
0
22
682
464
464
132
193
2
83
4
243
335
30
110
113
28
80
5
8
2
0
2
-5,745
1
12
9
7
2
2
2279121-5,745202858028113110303352434832193132464464682220002019381,3851,6052,4401,9790000000000000-4-4-4-2110000036400004,3502504601,06020
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,210
0
0
0
0
0
0
0
0
0
0
755
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000075500000000003,210000000000000000000000000000000000000
       Net Receivables 
0
10
30
40
90
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
77
0
0
0
0
28
19
1
1
1
1
2
2
2
6
14
17
23
30
30
54
0
85
270
183
2
20
20218327085054303023171462221111192800007700000000000000000000000000000000000000904030100
       Other Current Assets 
0
160
430
540
150
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44
40
61
32
0
0
0
2
77
0
135
0
527
1,309
19
1
3
0
410
369
167
0
6
17
78
6
0
74
54
0
71
80
88
0
0
008880710547406781760167369410031191,30952701350772000326140440000000000000000000000000000001505404301600
   > Long-term Assets 
2,250
5,110
4,860
4,670
5,010
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
148
172
93
90
0
0
0
0
0
0
9,499
20,882
20,993
14,086
13,216
16,032
16,203
8,280
8,345
8,367
6,758
85
5,828
5,727
5,318
5,314
5,167
5,167
5,102
10,550
10,319
10,193
10,184
9,817
9,817
9,8179,81710,18410,19310,31910,5505,1025,1675,1675,3145,3185,7275,828856,7588,3678,3458,28016,20316,03213,21614,08620,99320,8829,499000000909317214812000000000000000000000000000005,0104,6704,8605,1102,250
       Property Plant Equipment 
0
410
440
450
670
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
98
97
93
90
0
0
0
0
0
1,563
1,563
1,667
1,650
1,688
1,540
1,603
1,637
1,569
1,594
1,617
7
6
5,750
5,649
5,239
5,235
5,167
5,167
5,102
6,032
5,800
5,674
5,666
5,299
5,299
5,2995,2995,6665,6745,8006,0325,1025,1675,1675,2355,2395,6495,750671,6171,5941,5691,6371,6031,5401,6881,6501,6671,5631,563000009093979812000000000000000000000000000006704504404100
       Goodwill 
0
4,600
4,370
4,130
3,890
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,065
6,065
6,065
6,248
6,370
5,833
6,072
6,203
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000006,2036,0725,8336,3706,2486,0656,0656,0650000000000000000000000000000000000000003,8904,1304,3704,6000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,264
11,264
11,264
4,194
4,194
6,672
6,672
6,711
6,751
6,751
6,751
79
79
79
79
79
0
0
0
4,518
4,518
4,518
4,518
4,518
0
04,5184,5184,5184,5184,51800079797979796,7516,7516,7516,7116,6726,6724,1944,19411,26411,26411,264000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,871
1,871
1,885
1,831
1,834
1,649
1,686
1,690
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001,6901,6861,6491,8341,8311,8851,8711,87100000000000000000000000000000000000000000000
       Long-term Assets Other 
2,250
100
50
90
450
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50
75
0
0
0
0
0
0
0
0
1,614
1,667
1,650
14,086
1,540
1,603
1,637
0
0
0
6,758
0
6
0
5,134
0
0
5,064
4,934
0
0
0
5,512
0
0
005,5120004,9345,064005,1340606,7580001,6371,6031,54014,0861,6501,6671,61400000000755000000000000000000000000000000045090501002,250
> Total Liabilities 
290
2,190
2,410
3,420
2,430
0
640
0
671
591
634
654
650
685
723
745
764
593
621
651
0
51
78
100
136
153
177
198
221
245
270
292
318
0
0
2,085
2,149
687
528
959
964
0
997
1,923
10,384
10,384
9,282
9,856
11,163
12,049
13,311
14,988
17,549
15,637
15,243
13,327
13,040
20,201
20,467
20,405
22,759
23,482
23,482
25,786
23,899
34,895
28,382
28,266
30,645
30,645
30,64530,64528,26628,38234,89523,89925,78623,48223,48222,75920,40520,46720,20113,04013,32715,24315,63717,54914,98813,31112,04911,1639,8569,28210,38410,3841,92399709649595286872,1492,0850031829227024522119817715313610078510651621593764745723685650654634591671064002,4303,4202,4102,190290
   > Total Current Liabilities 
30
1,790
1,950
2,920
2,040
0
640
0
671
591
634
654
650
685
723
745
764
593
621
651
0
51
78
100
136
153
177
198
221
245
270
292
318
0
0
1,940
2,049
632
518
959
964
0
997
1,923
5,962
5,962
2,247
2,857
3,952
5,391
6,362
7,788
17,549
15,637
15,243
13,327
13,040
14,562
14,899
14,929
17,165
17,838
17,838
20,229
18,728
29,252
22,748
22,503
25,752
25,752
25,75225,75222,50322,74829,25218,72820,22917,83817,83817,16514,92914,89914,56213,04013,32715,24315,63717,5497,7886,3625,3913,9522,8572,2475,9625,9621,92399709649595186322,0491,9400031829227024522119817715313610078510651621593764745723685650654634591671064002,0402,9201,9501,79030
       Short-term Debt 
0
660
660
660
510
0
454
0
487
408
421
433
423
438
211
211
490
315
204
348
0
38
56
72
93
0
0
143
163
179
197
214
235
0
0
1,803
1,848
230
180
20
20
20
20
925
2,211
4,779
591
1,295
0
2,265
2,898
3,105
0
10,335
10,186
8,987
0
9,732
9,391
8,784
0
0
9,514
10,954
0
7,748
8,095
8,637
0
9,168
9,16808,6378,0957,748010,9549,514008,7849,3919,73208,98710,18610,33503,1052,8982,26501,2955914,7792,211925202020201802301,8481,8030023521419717916314300937256380348204315490211211438423433421408487045405106606606600
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,803
1,848
230
180
20
20
20
20
0
2,211
506
591
1,295
2,071
2,265
2,898
3,105
10,001
10,335
10,186
8,987
9,019
9,309
9,187
8,784
8,931
9,514
10,026
10,766
7,010
7,565
7,916
8,457
8,439
0
08,4398,4577,9167,5657,01010,76610,0269,5148,9318,7849,1879,3099,0198,98710,18610,33510,0013,1052,8982,2652,0711,2955915062,2110202020201802301,8481,80300000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
95
0
91
94
123
125
131
150
169
174
174
174
185
197
0
13
20
25
39
38
42
44
43
48
52
52
53
0
0
138
201
402
338
600
605
0
637
649
775
775
923
918
1,057
1,209
1,324
1,245
2,828
3,109
4,036
3,123
3,129
3,693
4,079
4,348
6,883
7,178
7,178
7,772
4,929
8,290
8,652
8,953
4,784
4,784
4,7844,7848,9538,6528,2904,9297,7727,1787,1786,8834,3484,0793,6933,1293,1234,0363,1092,8281,2451,3241,2091,05791892377577564963706056003384022011380053525248434442383925201301971851741741741691501311251239491095000000
       Other Current Liabilities 
30
1,130
1,290
2,260
1,530
0
91
0
94
89
0
96
0
97
343
361
100
104
232
105
0
1
1
3
4
115
134
11
14
18
22
26
30
0
0
1,803
1,848
230
180
190
190
0
340
349
190
408
664
645
190
1,917
2,141
3,439
3,867
2,192
1,022
1,216
697
1,136
1,429
1,796
1,199
963
1,146
1,502
1,469
13,214
5,568
4,636
4,813
11,801
11,8014,8134,6365,56813,2141,4691,5021,1469631,1991,7961,4291,1366971,2161,0222,1923,8673,4392,1411,91719064566440819034934001901901802301,8481,8030030262218141113411543110105232104100361343970960899409101,5302,2601,2901,13030
   > Long-term Liabilities 
260
400
460
500
390
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
145
100
55
10
0
0
0
0
0
0
4,422
7,036
6,999
7,211
6,658
6,948
7,200
0
0
0
0
0
5,639
5,568
5,476
5,593
5,643
5,643
5,557
5,171
5,644
5,634
5,763
4,893
4,893
4,8934,8935,7635,6345,6445,1715,5575,6435,6435,5935,4765,5685,639000007,2006,9486,6587,2116,9997,0364,4220000001055100145000000000000000000000000000000390500460400260
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
145
100
55
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,639
0
0
0
0
0
0
0
0
0
0
0
0
0000000000005,639000000000000000000105510014500000000000000000000000000000000000
> Total Stockholder Equity
1,990
4,170
3,390
2,080
7,170
0
-640
0
-632
-585
-630
-654
-650
-685
-723
-745
-764
-593
-621
-651
0
-51
-78
-100
-135
-153
-177
-198
-221
-245
-270
-292
-318
1,979
2,452
-288
-552
406
-205
-959
-964
-964
-975
-1,165
-346
-286
11,731
12,612
4,854
1,269
2,727
1,461
-8,802
-6,850
-6,394
-6,288
-12,926
-14,287
-14,704
-14,985
-17,344
-18,210
-18,210
-20,630
-12,153
-23,529
-16,669
-16,585
-19,810
-19,810
-19,810-19,810-16,585-16,669-23,529-12,153-20,630-18,210-18,210-17,344-14,985-14,704-14,287-12,926-6,288-6,394-6,850-8,8021,4612,7271,2694,85412,61211,731-286-346-1,165-975-964-964-959-205406-552-2882,4521,979-318-292-270-245-221-198-177-153-135-100-78-510-651-621-593-764-745-723-685-650-654-630-585-6320-64007,1702,0803,3904,1701,990
   Common Stock
0
170
190
200
200
0
1
0
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
0
2
2
2
2
3
4
4
4
4
4
5
5
7
10
13
17
23
26
27
29
29
29
0
60
66
66
0
66
6606666600292929272623171310755444443222202222222200000000000001111111111110102002001901700
   Retained Earnings -101,184-101,184-97,443-97,632-102,994-91,278-98,552-96,108-96,108-94,695-91,056-89,743-88,236-86,164-78,829-77,799-76,134-77,332-65,782-63,129-61,656-57,442-48,128-38,807-36,990-36,990-35,062-33,9670-33,896-33,891-28,637-26,930-22,803-21,145-17,825-17,346-17,193-17,167-17,145-17,120-17,095-17,073-17,052-17,028-17,010-16,974-16,953-16,926-16,875-17,525-17,494-17,467-17,638-17,619-17,597-17,559-17,524-17,427-17,403-17,357-17,3070-17,1650-4,850-3,190-1,840-690-40
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
2,030
4,710
5,090
5,150
11,870
0
16,524
0
16,674
16,771
16,771
16,771
16,873
16,873
16,873
16,873
16,873
16,873
16,873
16,873
16,875
16,875
16,875
16,875
16,875
16,875
16,875
16,875
16,875
16,875
16,875
16,875
16,875
19,323
20,276
20,905
22,256
27,334
28,430
0
0
0
32,930
33,835
0
36,642
50,331
60,128
138
62,395
65,232
66,673
-346
69,186
71,384
72,322
-372
73,892
74,705
73,212
240
235
75,094
75,249
0
78,690
80,123
80,123
0
80,123
80,123080,12380,12378,690075,24975,09423524073,21274,70573,892-37272,32271,38469,186-34666,67365,23262,39513860,12850,33136,642033,83532,93000028,43027,33422,25620,90520,27619,32316,87516,87516,87516,87516,87516,87516,87516,87516,87516,87516,87516,87516,87516,87316,87316,87316,87316,87316,87316,87316,87316,77116,77116,77116,674016,524011,8705,1505,0904,7102,030



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue820
Cost of Revenue-3,755
Gross Profit-2,935-2,935
 
Operating Income (+$)
Gross Profit-2,935
Operating Expense-671
Operating Income-3,606-3,606
 
Operating Expense (+$)
Research Development0
Selling General Administrative552
Selling And Marketing Expenses0
Operating Expense671552
 
Net Interest Income (+$)
Interest Income0
Interest Expense-2,264
Other Finance Cost-0
Net Interest Income-2,264
 
Pretax Income (+$)
Operating Income-3,606
Net Interest Income-2,264
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-9,9062,693
EBIT - interestExpense = -9,906
-9,906
-7,642
Interest Expense2,264
Earnings Before Interest and Taxes (EBIT)-7,642-7,642
Earnings Before Interest and Taxes (EBITDA)-3,606
 
After tax Income (+$)
Income Before Tax-9,906
Tax Provision-0
Net Income From Continuing Ops-9,906-9,906
Net Income-9,906
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses4,426
Total Other Income/Expenses Net-6,3002,264
 

Technical Analysis of Cannapharmarx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cannapharmarx. The general trend of Cannapharmarx is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cannapharmarx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Cannapharmarx Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Supportย is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistanceย is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of CannaPharmaRx Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.0055 < 0.0055 < 0.0055.

The bearish price targets are: 0.003 > 0.002 > 0.002.

Know someone who trades $CPMD? Share this with them.๐Ÿ‘‡

CannaPharmaRx Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theย moving averageย of the selected period.

  • Moving averages are laggingย trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of CannaPharmaRx Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

CannaPharmaRx Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theย momentumย of theย selected period based on two moving averages.

  • MACD is aย lagging momentumย indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of CannaPharmaRx Inc.

CannaPharmaRx Inc Daily Moving Average Convergence/Divergence (MACD) ChartCannaPharmaRx Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of CannaPharmaRx Inc. The current adx is .

CannaPharmaRx Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Showsย the current trend.
  • Showsย potential entry signals.
  • Showsย ย potential exit signals.
  • Can be used to placeย trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of CannaPharmaRx Inc.

CannaPharmaRx Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumย indicator, meaning the signals are instant.
  • Rangesย between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of CannaPharmaRx Inc.

CannaPharmaRx Inc Daily Relative Strength Index (RSI) ChartCannaPharmaRx Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Comparesย a certain price to multiple prices ranging over time.

  • Leadingย momentumย indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Rangesย between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of CannaPharmaRx Inc.

CannaPharmaRx Inc Daily Stochastic Oscillator ChartCannaPharmaRx Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,ย the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of CannaPharmaRx Inc.

CannaPharmaRx Inc Daily Commodity Channel Index (CCI) ChartCannaPharmaRx Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of CannaPharmaRx Inc.

CannaPharmaRx Inc Daily Chande Momentum Oscillator (CMO) ChartCannaPharmaRx Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

ย Shows the current price relative to the highest high over the last 14 days.
ย 

  • Lagging momentum indicator
  • Ranging between 0 andย -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of CannaPharmaRx Inc.

CannaPharmaRx Inc Daily Williams %R ChartCannaPharmaRx Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldย 

Score

Let's take a look at the Bollinger Bands of CannaPharmaRx Inc.

CannaPharmaRx Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of CannaPharmaRx Inc.

CannaPharmaRx Inc Daily Average True Range (ATR) ChartCannaPharmaRx Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

ย Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of CannaPharmaRx Inc.

CannaPharmaRx Inc Daily On-Balance Volume (OBV) ChartCannaPharmaRx Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of CannaPharmaRx Inc.

CannaPharmaRx Inc Daily Money Flow Index (MFI) ChartCannaPharmaRx Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for CannaPharmaRx Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-12-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-30MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-01-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-30MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-31MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-03RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-17MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

CannaPharmaRx Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of CannaPharmaRx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.003
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Cannapharmarx with someone you think should read this too:
  • Are you bullish or bearish on Cannapharmarx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cannapharmarx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about CannaPharmaRx Inc

I send you an email if I find something interesting about CannaPharmaRx Inc.


Comments

How you think about this?

Leave a comment

Stay informed about CannaPharmaRx Inc.

Receive notifications about CannaPharmaRx Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.